440
Views
49
CrossRef citations to date
0
Altmetric
Reviews

Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease

&
Pages 1505-1517 | Published online: 28 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Philip M Hansbro, Grace V Scott, Ama-Tawiah Essilfie, Richard Y Kim, Malcolm R Starkey, Duc H Nguyen, Paul D Allen, Gerard E Kaiko, Ming Yang, Jay C Horvat & Paul S Foster. (2013) Th2 cytokine antagonists: potential treatments for severe asthma. Expert Opinion on Investigational Drugs 22:1, pages 49-69.
Read now
Maria Gabriella Matera, Luigino Calzetta, Andrea Segreti & Mario Cazzola. (2012) Emerging drugs for chronic obstructive pulmonary disease. Expert Opinion on Emerging Drugs 17:1, pages 61-82.
Read now

Articles from other publishers (47)

A. S. Levina, M. N. Repkova & V. F. Zarytova. (2023) Therapeutic Nucleic Acids Against Herpes Simplex Viruses (A Review). Russian Journal of Bioorganic Chemistry 49:6, pages 1243-1262.
Crossref
Shikha Thakur, Apurba Sinhari, Priti Jain & Hemant R. Jadhav. (2022) A perspective on oligonucleotide therapy: Approaches to patient customization. Frontiers in Pharmacology 13.
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology 271 299 .
Meenu Mehta, Keshav Raj Paudel, Shakti Dhar Shukla, Venkata Sita Rama Raju Allam, Vinod Kumar Kannaujiya, Nisha Panth, Amlan Das, Vipan Kumar Parihar, Amlan Chakraborty, Md Khadem Ali, Niraj Kumar Jha, Dikaia Xenaki, Qian Peter Su, Peter Richard Wich, Jon Adams, Philip Michael Hansbro, Dinesh Kumar Chellappan, Brian Gregory George Oliver & Kamal Dua. (2021) Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases. Journal of Controlled Release 337, pages 629-644.
Crossref
Yuan He, Yingmin Liang, Run Han, Wan-Liang Lu, Judith Choi Wo Mak & Ying Zheng. (2019) Rational particle design to overcome pulmonary barriers for obstructive lung diseases therapy. Journal of Controlled Release 314, pages 48-61.
Crossref
Tobias W.M. Keil, Daniel P. Feldmann, Gabriella Costabile, Qian Zhong, Sandro da Rocha & Olivia M. Merkel. (2019) Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 143, pages 61-69.
Crossref
Meenu Mehta, Deeksha, Devesh Tewari, Gaurav Gupta, Rajendra Awasthi, Harjeet Singh, Parijat Pandey, Dinesh Kumar Chellappan, Ridhima Wadhwa, Trudi Collet, Philip M. Hansbro, S Rajesh Kumar, Lakshmi Thangavelu, Poonam Negi, Kamal Dua & Saurabh Satija. (2019) Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases. Chemico-Biological Interactions 308, pages 206-215.
Crossref
Juergen Siepmann, Amina Faham, Sophie-Dorothée Clas, Ben J. Boyd, Vincent Jannin, Andreas Bernkop-Schnürch, Hang Zhao, Sébastien Lecommandoux, James C. Evans, Christine Allen, Olivia M. Merkel, Gabriella Costabile, Morgan R. Alexander, Ricky D. Wildman, Clive J. Roberts & Jean-Christophe Leroux. (2019) Lipids and polymers in pharmaceutical technology: Lifelong companions. International Journal of Pharmaceutics 558, pages 128-142.
Crossref
Gail M. Gauvreau, Beth E. Davis & John Paul Oliveria. 2018. Oligonucleotide-Based Drugs and Therapeutics. Oligonucleotide-Based Drugs and Therapeutics 355 388 .
Wupeng Liao, Jinrui Dong, Hong Peh, Lay Tan, Kah Lim, Li Li & Wai-Shiu Wong. (2017) Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases. Molecules 22:1, pages 139.
Crossref
Sterghios A. Moschos, Louise Usher & Mark A. Lindsay. (2017) Clinical potential of oligonucleotide-based therapeutics in the respiratory system. Pharmacology & Therapeutics 169, pages 83-103.
Crossref
Antoine Monsel, Ying‐gang Zhu, Varun Gudapati & Jae‐Woo Lee. 2016. The Biology and Therapeutic Application of Mesenchymal Cells. The Biology and Therapeutic Application of Mesenchymal Cells 553 572 .
E. Ratemi, A. Sultana Shaik, A. Al Faraj & R. Halwani. (2016) Alternative approaches for the treatment of airway diseases: focus on nanoparticle medicine. Clinical & Experimental Allergy 46:8, pages 1033-1042.
Crossref
Victoria Capel, Driton Vllasaliu, Peter Watts & Snow Stolnik. (2016) Insight into the relationship between the cell culture model, cell trafficking and siRNA silencing efficiency. Biochemical and Biophysical Research Communications 477:2, pages 260-265.
Crossref
Rabab M. Elbehidy, Doaa M. Youssef, Amal S. El-Shal, Sally M. Shalaby, Hanan S. Sherbiny, Laila M. Sherief & Nagwa E Akeel. (2016) MicroRNA–21 as a novel biomarker in diagnosis and response to therapy in asthmatic children. Molecular Immunology 71, pages 107-114.
Crossref
Chrysanthi Skevaki, Christoph Hudemann & Harald Renz. 2016. Compendium of Inflammatory Diseases. Compendium of Inflammatory Diseases 678 686 .
Clive Page & Mario Cazzola. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD 197 212 .
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta & Mario Cazzola. (2014) Phosphodiesterase Inhibitors for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?. Drugs 74:17, pages 1983-1992.
Crossref
Denise S. Conti, Daniel Brewer, Jordan Grashik, Sumant Avasarala & Sandro R. P. da Rocha. (2014) Poly(amidoamine) Dendrimer Nanocarriers and Their Aerosol Formulations for siRNA Delivery to the Lung Epithelium. Molecular Pharmaceutics 11:6, pages 1808-1822.
Crossref
Yu Fujita, Yusuke Yoshioka, Saburo Ito, Jun Araya, Kazuyoshi Kuwano & Takahiro Ochiya. (2014) Intercellular Communication by Extracellular Vesicles and Their MicroRNAs in Asthma. Clinical Therapeutics 36:6, pages 873-881.
Crossref
Ben Forbes, Raegan O'Lone, Philippa Pribul Allen, Anthony Cahn, Chris Clarke, Mark Collinge, Lea Ann Dailey, Louise E. Donnelly, Joseph Dybowski, David Hassall, Deon Hildebrand, Rhys Jones, Joanne Kilgour, Jan Klapwijk, Curtis C. Maier, Tim McGovern, Kristen Nikula, Joel D. Parry, Matthew D. Reed, Ian Robinson, Lindsay Tomlinson & Alison Wolfreys. (2014) Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses. Advanced Drug Delivery Reviews 71, pages 15-33.
Crossref
Clare L. Ross & Trevor T. Hansel. (2014) New Drug Therapies for COPD. Clinics in Chest Medicine 35:1, pages 219-239.
Crossref
Chrysanthi Skevaki, Christoph Hudemann & Harald Renz. 2015. Encyclopedia of Inflammatory Diseases. Encyclopedia of Inflammatory Diseases 1 9 .
Ye Tian, Jian Chen, Fatemeh Zahtabi, Richard Keijzer & Malcolm Xing. (2013) Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases. Pediatric Pulmonology 48:11, pages 1098-1111.
Crossref
Yan Huang, Samir N. Ghadiali & S. Patrick Nana-Sinkam. 2013. microRNAs in Toxicology and Medicine. microRNAs in Toxicology and Medicine 77 99 .
Daniela De Stefano, Ciro Coletta, Roberta d’Emmanuele di Villa Bianca, Lucia Falcone, Ivana d’ Angelo, Francesca Ungaro, Fabiana Quaglia, Rosa Carnuccio & Raffaella Sorrentino. (2013) A Decoy Oligonucleotide to NF-κB Delivered through Inhalable Particles Prevents LPS-Induced Rat Airway Inflammation. American Journal of Respiratory Cell and Molecular Biology 49:2, pages 288-295.
Crossref
Mahmoud Kandeel & Yukio Kitade. (2013) In silico molecular docking analysis of the human Argonaute 2 PAZ domain reveals insights into RNA interference. Journal of Computer-Aided Molecular Design 27:7, pages 605-614.
Crossref
Ciara Kelly, Awadh B. Yadav, Paul J. McKiernan, Catherine M. Greene & Sally-Ann Cryan. 2013. Advanced Delivery and Therapeutic Applications of RNAi. Advanced Delivery and Therapeutic Applications of RNAi 391 416 .
Emma L. Beckett, Richard L. Stevens, Andrew G. Jarnicki, Richard Y. Kim, Irwan Hanish, Nicole G. Hansbro, Andrew Deane, Simon Keely, Jay C. Horvat, Ming Yang, Brian G. Oliver, Nico van Rooijen, Mark D. Inman, Roberto Adachi, Roy J. Soberman, Sahar Hamadi, Peter A. Wark, Paul S. Foster & Philip M. Hansbro. (2013) A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. Journal of Allergy and Clinical Immunology 131:3, pages 752-762.e7.
Crossref
Yu Fujita, Fumitaka Takeshita, Kazuyoshi Kuwano & Takahiro Ochiya. (2013) RNAi Therapeutic Platforms for Lung Diseases. Pharmaceuticals 6:2, pages 223-250.
Crossref
Wendy Halpern & David Hutto. 2013. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology 751 782 .
Asya S. Levina, Marina N. Repkova, Zinfer R. Ismagilov, Nadezhda V. Shikina, Ernst G. Malygin, Natalia A. Mazurkova, Victor V. Zinov'ev, Alexei A. Evdokimov, Sergei I. Baiborodin & Valentina F. Zarytova. (2012) High-performance method for specific effect on nucleic acids in cells using TiO2~DNA nanocomposites. Scientific Reports 2:1.
Crossref
Tania Maes, Guy F. Joos & Guy G. Brusselle. (2012) Targeting Interleukin-4 in Asthma: Lost in Translation?. American Journal of Respiratory Cell and Molecular Biology 47:3, pages 261-270.
Crossref
Francesca Ungaro, Ivana d' Angelo, Agnese Miro, Maria I La Rotonda & Fabiana Quaglia. (2012) Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises. Journal of Pharmacy and Pharmacology 64:9, pages 1217-1235.
Crossref
M. Dong, T.E. Mürdter, C. Philippi, B. Loretz, U.F. Schaefer, C.-M. Lehr, M. Schwab & S. Ammon-Treiber. (2012) Pulmonary delivery and tissue distribution of aerosolized antisense 2′-O-Methyl RNA containing nanoplexes in the isolated perfused and ventilated rat lung. European Journal of Pharmaceutics and Biopharmaceutics 81:3, pages 478-485.
Crossref
Xiangang Hu, Kurt Lomas Tulsieram, Qixing Zhou, Li Mu & Jianping Wen. (2012) Polymeric nanoparticle–aptamer bioconjugates can diminish the toxicity of mercury in vivo. Toxicology Letters 208:1, pages 69-74.
Crossref
Jenny Ka-Wing Lam, Wanling Liang & Hak-Kim Chan. (2012) Pulmonary delivery of therapeutic siRNA. Advanced Drug Delivery Reviews 64:1, pages 1-15.
Crossref
Gwyneth Davies, Eric W.F.W. Alton & Jane C. Davies. 2012. Kendig & Chernickâs Disorders of the Respiratory Tract in Children. Kendig & Chernickâs Disorders of the Respiratory Tract in Children 309 316 .
Tania Maes, Kurt G. Tournoy & Guy F. Joos. (2011) Gene Therapy for Allergic Airway Diseases. Current Allergy and Asthma Reports 11:2, pages 163-172.
Crossref
Daniela De Stefano, Francesca Ungaro, Concetta Giovino, Antonio Polimeno, Fabiana Quaglia & Rosa Carnuccio. (2011) Sustained inhibition of IL‐6 and IL‐8 expression by decoy ODN to NF‐κB delivered through respirable large porous particles in LPS‐stimulated cystic fibrosis bronchial cells. The Journal of Gene Medicine 13:4, pages 200-208.
Crossref
Nancy Elizabeth Larocca, Dolores Moreno, Jenny Valentina Garmendia & Juan Bautista De Sanctis. (2011) NEW PHARMACOLOGICAL TREATMENTS FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PUMONARY DISEASE (COPD). Biomedical Papers 155:1, pages 43-50.
Crossref
Alessandra Mescalchin & Tobias Restle. (2011) Oligomeric Nucleic Acids as Antivirals. Molecules 16:2, pages 1271-1296.
Crossref
Jia-wang Wang, Kunyu Li, Gary Hellermann, Richard F. Lockey, Subhra Mohapatra & Shyam Mohapatra. (2011) Regulating the Regulators: microRNA and Asthma. World Allergy Organization Journal 4:6, pages 94-103.
Crossref
Lili Jiang, Qin Huang, Siyang Zhang, Qingfu Zhang, Jihong Chang, Xueshan Qiu & Enhua Wang. (2010) Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer 10:1.
Crossref
Irene K Oglesby, Noel G McElvaney & Catherine M Greene. (2010) MicroRNAs in inflammatory lung disease - master regulators or target practice?. Respiratory Research 11:1.
Crossref
Francesca Ungaro, Concetta Giovino, Ciro Coletta, Raffaella Sorrentino, Agnese Miro & Fabiana Quaglia. (2010) Engineering gas-foamed large porous particles for efficient local delivery of macromolecules to the lung. European Journal of Pharmaceutical Sciences 41:1, pages 60-70.
Crossref
Shiyue Fang & Suntara Fueangfung. (2010) Scalable Synthetic Oligodeoxynucleotide Purification with Use of a Catching by Polymerization, Washing, and Releasing Approach. Organic Letters 12:16, pages 3720-3723.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.